Business Development Associate

Remote

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life Sciences, BiopharmaIndustries

Requirements

Candidates should have 2-4 years of experience in business development, sales, or client-facing roles within the life sciences or biotech tools/services sector. Familiarity with biomanufacturing and CMC functions, including cell line development, process development, or viral vector production, is required. Strong communication and organizational skills are necessary, along with a team player mindset and a Bachelor's degree in Life Sciences, Bioengineering, Biochemistry, or a related field; advanced degrees are a plus.

Responsibilities

The Business Development Associate will support revenue growth by identifying and qualifying new opportunities with biopharma companies. Responsibilities include building and maintaining a sales funnel through lead generation and outbound outreach, assisting in proposal development and deal structuring, and supporting client communications. The role involves collaborating with cross-functional teams, representing Asimov at industry events, and ensuring CRM accuracy and sales metric tracking.

Skills

Business Development

Sales

Client-facing roles

Life Sciences

Biotech Tools/Services

Biomanufacturing

CMC Functions

Cell Line Development

Process Development

Viral Vector Production

Communication

Organization

CRM

Sales Metrics

Asimov

Synthetic biology solutions for biopharmaceuticals

About Asimov

Asimov operates in the synthetic biology field, providing a combination of cells, genes, and software to assist in advanced genetic design. Their products include cloud-based software that allows clients in the biopharmaceutical industry to design, simulate, and optimize genetic systems. Additionally, they offer engineered GMP host cells that are used for therapeutic applications. Asimov distinguishes itself from competitors by guaranteeing high titer cell lines for monoclonal antibodies with a promise of '4 g/L or it's free,' which reduces risk for their clients. The company's goal is to enable biopharma companies to produce high-quality protein therapeutics and scalable viral vectors efficiently, supported by their in-house expertise in synthetic biology and process development.

Boston, MassachusettsHeadquarters

2017Year Founded

$199.1MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Risks

Competition from LatchBio's code-free biocomputing infrastructure challenges Asimov's software offerings.

Integration of The Foundry may lead to potential cultural clashes and operational disruptions.

Rapid data generation in synthetic biology may strain Asimov's data processing capabilities.

Differentiation

Asimov offers a '4 g/L or it's free' promise for monoclonal antibodies.

The LV Edge Producer System eliminates GMP plasmid costs and reduces process complexity.

Asimov integrates synthetic biology, computer-aided design, and machine learning for genetic design.

Upsides

Stable cell line development reduces costs and increases scalability in lentiviral production.

Acquisition of The Foundry enhances Asimov's expertise in genetic design and engineering.

Growing biotech investments indicate a robust market for Asimov's engineered cell lines.

Land your dream remote job 3x faster with AI

Try Jobo Free